Libevitug works by blocking hepatitis B and D viruses from entering liver cells, targeting the PreS1 domain of the viral ...

UF Health transplant programs continue to be among the nation’s elite, including best-in-category results for the UF Health ...

Like most new parents, Ahad and Hira Ul Hassan keep a close eye out for signs that their one-year-old son Zohan is developing ...

Cancer is transported from one organ to another by invisible bubbles. Understanding these microscopic messengers could change ...

Researchers at Carnegie Mellon University are revolutionizing medical care for diseases that impact millions of Americans and the treatments they develop could alleviate major public health challenges ...

Metabolic diseases such as obesity, fatty liver, and insulin resistance are rapidly increasing worldwide, but fundamental ...

After a spate of patient deaths in 2025 linked to the company’s Duchenne gene therapy, Sarepta shared new data showing ...

Mirum Pharmaceuticals’ acquisition of Bluejay Therapeutics adds brelovitug to its pipeline, positioning the company for a potential first approved treatment for chronic hepatitis delta virus while ...

Sarepta Therapeutics' gene ‌therapy for Duchenne muscular dystrophy slowed disease progression and showed sustained benefit ...

Bausch Health said on Friday its experimental treatment failed to prevent the first clinically visible symptoms of a neurological ​condition in patients with a type of liver disease, missing ‌the main ...

We often think of ourselves as more capable than we really are. For example, according to this survey, four in five Americans ...